Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Falling Comet

2608.6000 43.20 (1.68%)

NSE Apr 15, 2025 10:08 AM

25.15% Fall from 52W High

Volume: 22,421

Ajanta Pharma Ltd.

06 May 2023

2608.60

1.68%

Ajanta Pharma (BUY): Margins appear to have bottomed out; raise to BUY

Buy: Ajanta Pharma Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Strong India and US growth in Q4 (17% YoY each) offset by declines in other businesses

Ajanta Pharma Ltd.'s price crossed above 50Day SMA today